Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 49, Issue 19, Pages 5645-5648Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm060559v
Keywords
-
Categories
Ask authors/readers for more resources
The fumagillin family of natural products inhibits angiogenesis through the irreversible inhibition of the type 2 methionine aminopeptidase (MetAP2). Herein is reported a novel fumagillin analogue named fumarranol. It is shown that, like fumagillin, fumarranol selectively inhibits MetAP2 and endothelial cell proliferation. It is also active in a mouse model of angiogenesis in vivo. Unlike TNP-470, fumarranol does not covalently bind to MetAP2. Fumarranol may serve as a lead for a new class of angiogenesis inhibitors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available